Antithrombin III is associated with acute liver failure in patients with end-stage heart failure undergoing mechanical circulatory support

Yancy, 2013, 3013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, Circulation, 15, e240 Pagani, 1999, Extracorporeal life support to left ventricular assist device bridge to heart transplantation, Circulation, 100, II-206, 10.1161/01.CIR.100.suppl_2.II-206 Hoefer, 2006, Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock, Ann Thorac Surg, 82, 28, 10.1016/j.athoracsur.2006.02.056 Metra, 2012, Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function, Circ Heart Fail, 5, 54, 10.1161/CIRCHEARTFAILURE.111.963413 Metra, 2012, The role of the kidney in heart failure, Eur Heart J, 33, 2135, 10.1093/eurheartj/ehs205 Nikolaou, 2013, Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure, Eur Heart J, 34, 742, 10.1093/eurheartj/ehs332 Bart, 2012, Ultrafiltration in decompensated heart failure with cardiorenal syndrome, N Engl J Med, 367, 2296, 10.1056/NEJMoa1210357 Seeto, 2000, Ischemic hepatitis: clinical presentation and pathogenesis, Am J Med, 109, 109, 10.1016/S0002-9343(00)00461-7 Naschitz, 2000, Heart diseases affecting the liver and liver diseases affecting the heart, Am Heart J, 140, 111, 10.1067/mhj.2000.107177 O'Grady, 1989, Early indicators of prognosis in fulminant hepatic failure, Gastroenterology, 97, 439, 10.1016/0016-5085(89)90081-4 Mizuguchi, 2012, Serum antithrombin III level is well correlated with multiple indicators for assessment of liver function and diagnostic accuracy for predicting postoperative liver failure in hepatocellular carcinoma patients, Hepatogastroenterology, 59, 551 Isik, 2012, Antithrombin prevents apoptosis by regulating inflammation in the liver in a model of cold ischemic/warm reperfusion injury, Hepatogastroenterology, 59, 453, 10.5754/hge11317 Ostrovski, 1997, Antithrombin III prevents and rapidly reverses leucocyte recruitment in ischemia/reperfusion, Circulation, 96, 2302, 10.1161/01.CIR.96.7.2302 Inthorn, 1997, Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction, Shock, 8, 328, 10.1097/00024382-199711000-00003 Dhainaut, 2001, Hepatic response to sepsis: interaction between coagulation and inflammatory processes, Crit Care Med, 29, S42, 10.1097/00003246-200107001-00016 Arcidi, 1981, Hepatic morphology in cardiac dysfunction. A clinicopathologic study of 1000 subjects at autopsy, Am J Pathol, 104, 159 Lam, 2011, Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community, Circulation, 124, 24, 10.1161/CIRCULATIONAHA.110.979203 Denis, 2004, Acute hypoxic hepatitis (“liver shock”): still a frequently overlooked cardiologic diagnosis, Eur J Heart Fail, 6, 561, 10.1016/j.ejheart.2003.12.008 Ruttmann, 2005, Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults, Circulation, 112, 2130, 10.1161/CIRCULATIONAHA.105.552547 Poelzl, 2012, Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance, Eur J Clin Invest, 42, 153, 10.1111/j.1365-2362.2011.02573.x Florath, 2006, Current determinants of 30-day and 3-month mortality in over 2000 aortic valve replacements: impact of routine laboratory parameters, Eur J Cardiothorac Surg, 30, 716, 10.1016/j.ejcts.2006.08.009 Allen, 2009, For the CHARM investigators. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program, Eur J Heart Fail, 11, 170, 10.1093/eurjhf/hfn031 Russell, 2009, Renal and hepatic function improve in in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device, Circulation, 120, 2352, 10.1161/CIRCULATIONAHA.108.814863 Ruggenenti, 2011, Worsening kidney function in decompensated heart failure: treat the heart, don't mind the kidney, Eur Heart J, 32, 2476, 10.1093/eurheartj/ehr242